Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Turkish Journal of Internal Medicine
Volume:3 Issue:1
Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus

Oral Glucose-Lowering Agent Treatments in Type 2 Diabetes Mellitus

Pages : 1-5

View : 19 | Download : 9

Publication Date : 2021-01-29

Article Type : Editorial

Abstract :Type 2 diabetes is manifested by impaired insulin secretion in pancreatic beta cells, increased glucagon secretion in alpha cells, and generally has a history of insulin resistance. The treatment of glucose metabolism disorder and the resulting hyperglycemia constitute an important part of the treatment of type 2 diabetes. Glycemic targets can be targeted with A1C <7% to reduce the risk of micro and macrovascular complications in eligible patients, and A1C <6.5% to reduce the risk of diabetic chronic renal failure and retinopathy in those with low risk of hypoglycemia. We can consider the treatment of hyperglycemia in two components; lifestyle changes and glucose-lowering agent therapy.
Keywords : Type 2 diabetes, oral treatment, anti diabetics

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.